Posted on October 21, 2018 by Sitemaster
New data from the ongoing STAMPEDE trial in the UK and Switzerland has now confirmed that ablative radiation of the prostate itself (debulking of the primary tumor) improves overall survival (OS) in men newly diagnosed with metastatic prostate cancer who have a low metastatic disease burden but not in those with higher burden of disease. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen, debulking, deprivation, docetaxel, metastasis, primary, radiation, therapy, tumor | 6 Comments »
Posted on October 16, 2018 by Sitemaster
Posted on October 13, 2018 by Sitemaster
It will come as no surprise to our readers that moderately hypofractionated IMRT (first-line radiation delivered in 20 to 26 treatments or fractions instead of the conventional 40-44 fractions) has received strong endorsement from all of the major US organizations of physicians who treat prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: guideline, hypofractionation, radiation, therapy | Leave a comment »
Posted on October 13, 2018 by Sitemaster
As we reported last year, a new radiopharmaceutical has entered the pack. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: castration-resistant, injectable, Iodine-131-MIP-1095, metastatic, radiation, systenic, therapy | 3 Comments »
Posted on October 1, 2018 by Sitemaster
The term “debulking” denotes the radical treatment (via prostatectomy or radiation therapy) of the cancerous prostate — lmost always in newly diagnosed patients — after distant metastases have been discovered. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: debulking, primary, prostatectomy, radiation, therapy, trial, tumor | 24 Comments »
Posted on September 10, 2018 by Sitemaster
Meier et al. have just published updated results of a 5-year multi-institutional trial finding that stereotactic body radiation therapy (SBRT) had high rates of cancer control and low toxicity. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: bod, outcomes, radiation, SBRT, stereotactic | 6 Comments »
Posted on September 4, 2018 by Sitemaster
A randomized clinical trial of the 68Ga-PSMA-11 PET indicator for men with a recurrence after radical prostatectomy has just been initiated at the University of California Los Angeles (UCLA). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: gallium-68, PET, radiation, salvage, scan, trial | 1 Comment »
